Business Standard

Sun Pharma Q1 net profit soars 43% YoY to Rs 2,061 cr; revenue up 10%

It has reported an Ebitda (earnings before interest, tax, depreciation and ammortisation) of Rs 2,884 crore (including other operating revenues), with the Ebitda margin at 26.8 per cent.

pharma
Premium

Harshita Singh New Delhi
Mumbai-based Sun Pharmaceutical Industries posted a 43 per cent rise in net profits to Rs 2,061 crore for the June quarter (Q1FY23). The company's net profit in the year ago period was Rs 1,444 crore, and in the March quarter, it had reported a net loss of Rs 2,277 crore.

The firm's revenue surged 9.7 per cent to Rs 10,762 crores, up from Rs 9,719 crore in the year-ago quarter. In the March quarter, it had posted revenues of Rs 9,447 crore. 

It has reported an Ebitda (earnings before interest, tax, depreciation and ammortisation) of Rs 2,884 crore (including

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 29 2022 | 2:25 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com